Trump’s Pharmaceutical Tariffs to Boost US Manufacturing?
Understand the implications of Trump's pharmaceutical tariffs as the administration signals a shift towards increased domestic production.
SA Pharma Sector Unfazed by US Tariffs Impact
The SA pharma sector is unfazed by US tariffs, as key leaders assess the situation, ensuring stability and security in the market.
Competition Commission probes insulin price fixing
The Competition Commission is investigating insulin manufacturers Novo Nordisk and Sanofi Aventis, raising concerns about accessibility to diabetes care.